Repligen | RGEN - Sales Revenues



Repligen reported $182M in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Agilent USD 1.74B 68M Jul/2025
Align Technology USD 1.01B 30.7M Jun/2025
Bio Techne USD 317M 820K Jun/2025
BioMarin Pharmaceutical USD 825M 80M Jun/2025
Bristol-Myers Squibb USD 12.27B 1.07B Jun/2025
Bruker USD 797.4M 4M Jun/2025
Charles River Laboratories USD 1.03B 45.8M Jun/2025
Danaher USD 5.94B 200M Jun/2025
Dentsply International USD 936M 57M Jun/2025
Exact Sciences USD 811.1M 104.1M Jun/2025
General Electric Aerospace USD 10.15B 210M Jun/2025
Henry Schein USD 3.2B 30M Jun/2025
Illumina USD 1.06B 20M Jun/2025
IQVIA Holdings USD 4.02B 190M Jun/2025
Mettler Toledo International USD 983.22M 99.48M Jun/2025
Myriad Genetics USD 213.1M 17.2M Jun/2025
Pfizer USD 14.7B 980M Jun/2025
Repligen USD 182M 13M Jun/2025
Revvity USD 720M 55M Jun/2025
Standard Biotools USD 21.76M 24.96M Jun/2025
Thermo Fisher Scientific USD 10.85B 490M Jun/2025
Waters USD 771M 109M Jun/2025
West Pharmaceutical Services USD 766.5M 68.5M Jun/2025